牛津大学疫苗公布重大进展，但并未令市场信服，阿斯利康公司股价下跌

昨日牛津大学与阿斯利康公司(AstraZeneca Plc )合作开发的冠状病毒疫苗在早期人体试验中显示出了令人鼓舞的结果，现在也正准备进入更大规模的试验中，这些试验对验证疫苗真正的有效性起决定性作用。然而，这个结果似乎并不足以让市场和民众信服。阿斯利康公司股价竟然从纽约股市的历史高点下跌。市场主要还是担心此疫苗能否与辉瑞公司（Pfizer Inc.）和德国BioNtech SE公司以及美國莫德納公司（Moderna Inc.）等生物技术公司项目的进展相媲美。

A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, and is now set to move into larger trials that are likely to be decisive on how effective they truly are.The results weren’t enough to convince the market, however. AstraZeneca Plc fell from a record high in New York trading on concerns over whether its vaccine can match the progress seen in programs from Pfizer Inc. and BioNtech SE, as well as Moderna Inc.  source

指尖新闻：高信噪比，一目了然

新冠疫情追踪

wow not good news